X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2023/05/30/2678347/0/en/SAB-Biotherapeutics-to-Present-Novel-Human-IgG-Platform-with-Positive-Data-and-Breakthrough-Therapy-and-Fast-Track-Designations-for-Influenza-Treatment-at-BIO-2023-International-Co.html
https://www.globenewswire.com/news-release/2023/05/19/2672536/0/en/SAB-Biotherapeutics-Presents-Virtual-2023-R-D-Day-Portfolio-Update-Breakthrough-Immunotherapy-Innovations.html
https://www.globenewswire.com/news-release/2023/05/16/2669950/0/en/SAB-Biotherapeutics-Provides-Company-Update-for-Q1-2023-Financial-Results.html
https://www.globenewswire.com/news-release/2023/05/12/2667793/0/en/SAB-Biotherapeutics-Announces-First-Publication-of-Promising-Nonclinical-Data-for-SAB-183-Against-Pneumonic-Plague-in-the-Journal-Antibodies.html
https://www.globenewswire.com/news-release/2023/05/09/2664442/0/en/SAB-Biotherapeutics-Announces-Progress-on-U-S-FDA-s-Phased-Review-of-Company-s-Groundbreaking-DiversitAb-Platform.html
https://www.globenewswire.com/news-release/2023/05/04/2661515/0/en/SAB-Biotherapeutics-Presents-Positive-Phase-1-and-2a-Data-for-SAB-176-Influenza-Immunotherapy-at-ISIRV-AVG-Conference.html
https://www.globenewswire.com/news-release/2023/05/03/2660914/0/en/SAB-Biotherapeutics-to-Present-at-Sidoti-Virtual-Investor-Conference-May-10-11.html
https://www.globenewswire.com/news-release/2023/04/26/2655066/0/en/SAB-Biotherapeutics-Announces-Positive-Results-from-Phase-3-Trial-of-SAB-185-in-Patients-with-COVID-19-at-High-Risk-for-Severe-Complications.html
https://www.globenewswire.com/news-release/2023/04/18/2648996/0/en/SAB-Biotherapeutics-Announces-U-S-FDA-Grants-Breakthrough-Therapy-Designation-to-SAB-176-Influenza-Immunotherapy.html
https://www.globenewswire.com/news-release/2023/04/13/2646194/0/en/SAB-Biotherapeutics-Granted-Fast-Track-Designation-from-FDA-for-SAB-176-Influenza-Immunotherapy-with-High-Cross-Reactivity-to-Multiple-Strains-of-Influenza.html
Market Place
Share 
